Sequana Medical announces results of Special General Meeting of Shareholders
June 26, 2023 12:00 ET
|
Sequana Medical NV
PRESS RELEASEREGULATED INFORMATION26 June 2023, 06:00 pm CEST Dr. Kenneth Macleod appointed as non-executive director Ghent, Belgium – 26 June 2023 – Sequana Medical NV (Euronext Brussels: SEQUA)...
Sequana Medical announces additional data on safety, quality of life and survival from North American pivotal alfapump® study (POSEIDON)
June 21, 2023 01:00 ET
|
Sequana Medical NV
PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION21 June 2023, 07:00 am CEST Data presented at EASL Congress 2023 alfapump was effective in the control of ascites, virtually eliminating...
Additional data from North American pivotal alfapump® study (POSEIDON) will be presented at EASL Congress 2023
June 19, 2023 12:00 ET
|
Sequana Medical NV
PRESS RELEASE Poster presentation at EASL by Dr. Florence Wong on 21 June 2023; selected for additional poster presentation on 23 June 2023Conference call with live webcast by Sequana Medical on 21...
Sequana Medical wins Best Technology Award for alfapump® at European Mediscience Awards
June 16, 2023 01:00 ET
|
Sequana Medical NV
Ghent, Belgium – 16 June 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and...
Sequana Medical announces Special General Meeting of Shareholders on 26 June 2023
May 26, 2023 01:00 ET
|
Sequana Medical NV
PRESS RELEASEREGULATED INFORMATION26 May 2023, 07:00 am CEST Ghent, Belgium – 26 May 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the...
Sequana Medical announces results of Annual General Meeting of Shareholders
May 25, 2023 12:00 ET
|
Sequana Medical NV
PRESS RELEASEREGULATED INFORMATION25 May 2023, 06:00 pm CEST Ghent, Belgium – 25 May 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the...
Transparency Notifications from Shareholders
May 15, 2023 12:00 ET
|
Sequana Medical NV
PRESS RELEASEREGULATED INFORMATION 15 May 2023, 06:00 pm CEST Ghent, Belgium – 15 May 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the...
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
May 10, 2023 12:00 ET
|
Sequana Medical NV
PRESS RELEASEREGULATED INFORMATION10 May 2023, 06:00 p.m. CEST Ghent, Belgium, 10 May 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the...
Sequana Medical announces FDA clearance of IND application for DSR® 2.0 for treatment of congestive heart failure
May 02, 2023 01:00 ET
|
Sequana Medical NV
PRESS RELEASE MOJAVE study on track to start in Q2 2023 as planned, with initial data by year-end Randomized, controlled study in US seeking to confirm strong efficacy data seen in RED DESERT and...
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
April 27, 2023 13:00 ET
|
Sequana Medical NV
PRESS RELEASEREGULATED INFORMATION27 April 2023, 07:00 p.m. CEST Ghent, Belgium, 27 April 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the...